Intrust Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
NMC
BG
AG
Intrust Bank's AUPH Position: Q1 2022 in Review
Intrust Bank sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2022, closing a stake of 8,928 shares — an estimated $204K sold.
Intrust Bank first reported a position in AUPH in Q3 2021 and held it in 2 quarters. The position peaked at $208K in Q3 2021. 184 funds tracked by Wall St. Rank hold AUPH as of Q1 2022.
- Intrust Bank reported no remaining Aurinia Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
- Intrust Bank sold 8,928 Aurinia Pharmaceuticals shares in Q1 2022, an estimated $204K.
- Intrust Bank first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 2 quarters.
- Intrust Bank's Aurinia Pharmaceuticals position peaked at $208K in Q3 2021.
- 184 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2022.
Based on Intrust Bank's 13F filing for Q1 2022, filed 10 May 2022.